Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Long-term survivors of childhood cancers: what knowledge have we gained?

Nature Clinical Practice Oncology volume 1, pages 26–31 (2004)Cite this article

Abstract

Currently, in the US and Western Europe about 75% of children diagnosed with cancer survive at least 5 years and most survivors are cured. Unfortunately, survivors are at an increased risk of a range of adverse health outcomes compared with that expected from the general population. Large-scale studies of mortality occurring beyond 5-year survival show that the majority of the deaths in the initial decade are because of recurrent tumors. Thereafter, other causes of death that occur increasingly including second malignant neoplasms, cardiac deaths and pulmonary deaths. During the past 25 years, research has focused on estimating the risks of such long-term 'effects' of childhood cancer and its treatment. Studies have examined how risks vary in relation to a range of factors that include treatment exposures, age at treatment, type of childhood cancer, duration of follow-up, and factors that may genetically predispose a survivor to particular complications. This information is critical to counsel survivors and their families in relation to long-term risks and identify specific groups of survivors who are at particularly high risk—with a view to earlier diagnosis or intervention and provide the means of assessing potential benefits and risks of different proposals for future treatment protocols.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Gatta G et al. (2002) Childhood Cancer Survival in Europe and the United States. Cancer 95: 1767–1772

    Article  Google Scholar 

  2. Kroll M et al. Childhood Cancer – UK. In Cancer Research UK Monograph, Cancer Research UK, in press

  3. Robison LL et al. (2002) Study design and cohort characteristics of the Childhood Cancer Survivor Study: A multi-institutional collaborative project. Med Pediatr Oncol 38: 229–239

    Article  Google Scholar 

  4. Taylor A et al. (2004) Long-term follow-up of survivors of childhood cancer in the UK. Pediatr Blood Cancer 42: 161–168

    Article  Google Scholar 

  5. Hawkins MM (1989) Long term survival and cure after childhood cancer. Arch Dis Child 64: 798–807

    Article  CAS  Google Scholar 

  6. Hawkins MM et al. (1990) Late deaths after treatment for childhood cancer. Arch Dis Child 65: 1356–1363

    Article  CAS  Google Scholar 

  7. Robertson CM et al. (1994) Late deaths and survival after childhood cancer: implications for cure. BMJ 309: 162–166

    Article  CAS  Google Scholar 

  8. Mertens AC et al. (2001) Late mortality experience in five-year survivors of childhood and adolscent cancer: The Childhood Cancer Survivor Study. J Clin Onc 19: 3163–3172

    Article  CAS  Google Scholar 

  9. Möller TR et al. (2001) Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: A population-based study in the Nordic countries. J Clin Oncol 19: 3173–3181

    Article  Google Scholar 

  10. Olsen JH et al. (1993) Second malignant neoplasms after cancer in childhood or adolescence. BMJ 307: 1030–1036

    Article  CAS  Google Scholar 

  11. Hawkins MM et al. (1987) Incidence of second primary tumors among childhood cancer survivors. Br J Cancer 56: 339–347

    Article  CAS  Google Scholar 

  12. Neglia JP et al. (2001) Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst 93: 618–629

    Article  CAS  Google Scholar 

  13. Wong FL et al. (1997) Cancer incidence after retinoblastoma: radiation dose and sarcoma risk. JAMA 278: 1262–1267

    Article  CAS  Google Scholar 

  14. Moll AC et al. (2001) Second primary tumors in hereditary retinoblastoma: A register-based study, 1945-1997: is there an age effect on radiation-related risk? Opthalmology 108: 1109–1114

    Article  CAS  Google Scholar 

  15. Hawkins MM et al. (1996) Radiotherapy, alkylating agents and risk of bone cancer after childhood cancer. J Natl Cancer Inst 88: 270–278

    Article  CAS  Google Scholar 

  16. Fletcher O et al. (2004) Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 96: 357–363

    Article  Google Scholar 

  17. Draper GJ et al. (1986) Second primary neoplasms in patients with retinoblastoma. Br J Cancer 53: 661–671

    Article  CAS  Google Scholar 

  18. Metayer C et al. (2000) Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol 18: 2435–2443

    Article  CAS  Google Scholar 

  19. Sankila R et al. (1996) Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology. J Clin Oncol 14: 1442–1446

    Article  CAS  Google Scholar 

  20. Wolden SL et al. (1998) Second cancers following pediatric Hodgkin's disease. J Clin Oncol 16: 536–544

    Article  CAS  Google Scholar 

  21. Bhatia S et al. (2003) High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 21: 4386–4394

    Article  Google Scholar 

  22. Travis LB et al. (2003) Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 290: 465–475

    Article  Google Scholar 

  23. van Leeuwen FE et al. (2003) Roles of radiation dose, chemotherapy and hormonal factors in breast cancer following Hodgkin's disease. J Natl Cancer Inst 95: 971–980

    Article  Google Scholar 

  24. Hinkle AS et al. (2004) Cardiotoxicity caused by chemotherapy. In Late Effects of Childhood Cancer, 85–100 (Eds WHB Wallace and D Green) London: Arnold Publishers

    Google Scholar 

  25. Levitt GA and Saran FH (2004) Radiation damage. In Late Effects of Childhood Cancer, 101–113 (Eds WHB Wallace, D Green) London: Arnold Publishers

    Google Scholar 

  26. Giantris A et al. (1998) Anthracycline-induced cardiotoxicity in children and young adults. Critical Reviews Oncol/Hematol 27: 53–68

    Article  CAS  Google Scholar 

  27. Krischer JP et al. (1997) Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The Pediatric Oncology Group experience. J Clin Oncol 15: 1544–1552

    Article  CAS  Google Scholar 

  28. Grenier MA and Lipshultz SE (1998) Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol 25 (Suppl): S72–S85

    Google Scholar 

  29. Green DM et al. (2001) Congestive heart failure after treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 19: 1926–1934

    Article  CAS  Google Scholar 

  30. Wexler LH et al. (1996) Randomized trial of the cardioprotective agent ICRF-187 in pediatric sarcoma patients treated with doxorubicin. J Clin Oncol 14: 362–372

    Article  CAS  Google Scholar 

  31. Lipshultz SE et al. (2004) The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia. N Engl J Med 351: 145–153

    Article  CAS  Google Scholar 

  32. Kremer LCM and Caron HN (2004) Anthracycline cardiotoxicity in children. N Engl J Med 351: 120–121

    Article  CAS  Google Scholar 

  33. Hancock SL et al. (1993) Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 11: 1208–1215

    Article  CAS  Google Scholar 

  34. Darzy KH et al. (2004) Growth and neuroendocrine consequences. In Late Effects of Childhood Cancer, 189–211 (Eds WHB Wallace and D Green) London: Arnold Publishers

    Google Scholar 

  35. Swerdlow AJ et al. (2002) Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 360: 273–277

    Article  CAS  Google Scholar 

  36. Sklar CA et al. (2002) Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 87: 3136–3141

    Article  CAS  Google Scholar 

  37. Rose SR et al. Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. J Clin Endocrinol Metab 84: 4472–4479

  38. Rose SR (2001) Cranial irradiation and central hypothyroidism. Trends Endocrinol Metab 12: 97–104

    Article  CAS  Google Scholar 

  39. Sklar C et al. (2000) Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 85: 3227–3232

    CAS  PubMed  Google Scholar 

  40. Byrne J et al. (1987) Effects of treatment on fertility in long term survivors of childhood or adolescent cancer. N Engl J Med 317: 1315–1321

    Article  CAS  Google Scholar 

  41. Critchley HOD et al. (2004) Ovarian and uterine function and reproductive potential. In Late Effects of Childhood Cancer, 225–238 (Eds WHB Wallace and D Green) London: Arnold Publishers

    Google Scholar 

  42. Thomson AB et al. (2004) Testicular function. In Late Effects of Childhood Cancer, 239–256 (Eds WHB Wallace and D Green) London: Arnold Publishers

    Google Scholar 

  43. Wallace WHB, Green D (Eds) (2004) In Late Effects of Childhood Cancer, London, Arnold Publishers

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Reader in Epidemiology and Director of the Centre for Childhood Cancer Survivor Studies at the University of Birmingham,

    Mike M Hawkins

Authors
  1. Mike M Hawkins
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mike M Hawkins.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hawkins, M. Long-term survivors of childhood cancers: what knowledge have we gained?. Nat Rev Clin Oncol 1, 26–31 (2004). https://doi.org/10.1038/ncponc0020

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0020

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing